Showing results (101-110 of 830) with videos related to

Sort By:
Pageof 83
Pharmacogenetics|October 19, 2000
Role of cytochrome P450 2D6 (CYP2D6) in the stereospecific metabolism of E- and Z-doxepinV S Haritos, H Ghabrial, J T Ahokas, et al.
Pharmacogenetics|September 2, 1999
Polymorphic debrisoquine 4-hydroxylase activity in the rat is due to differences in CYP2D2 expressionT Schulz-Utermoehl, A J Bennett, S W Ellis, et al.
Pharmacogenetics|June 22, 2000
The relationship between genotype and chromosome aberration frequencies in a normal adult populationJ M Pluth, D O Nelson, M J Ramsey, et al.
Pharmacogenetics|June 22, 2000
Polymorphisms in P450 CYP1B1 affect the conversion of estradiol to the potentially carcinogenic metabolite 4-hydroxyestradiolD N Li, A Seidel, M P Pritchard, et al.
Pharmacogenetics|January 25, 2003
Role of CYP2D6 in the stereoselective disposition of venlafaxine in humansChin B Eap, Etienne Lessard, Pierre Baumann, et al.
Pharmacogenetics|January 25, 2003
Arylamine N-acetyltransferase (NAT2) genotypes in Africans: the identification of a new allele with nucleotide changes 481C>T and 590G>ACollet Dandara, Collen M Masimirembwa, Ayoub Magimba, et al.
Pharmacogenetics|February 4, 2003
The Gln27Glu beta2-adrenoceptor polymorphism slows the onset of desensitization of cardiac functional responses in vivoHeike Bruck, Kirsten Leineweber, Rainer Büscher, et al.
Pharmacogenetics|March 6, 2003
The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondriaAngela Sutton, Hania Khoury, Carina Prip-Buus, et al.
Pharmacogenetics|March 6, 2003
Prostate expression of N-acetyltransferase 1 (NAT1) and 2 (NAT2) in rapid and slow acetylator congenic Syrian hamsterDavid W Hein, Mark A Doll, Gong H Xiao, et al.
Pharmacogenetics|November 20, 2002
Lack of association of the codon 12 polymorphism of the peroxisome proliferator-activated receptor gamma gene with breast cancer and body massAsli Memisoglu, Susan E Hankinson, JoAnn E Manson, et al.
Pageof 83